Nieves Garcia-Gisbert

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 14, 2026
Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Marta Lafuente, Ramón Diez-Feijóo, Marta García-Recio

|Jan 23, 2024
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Ramón Diez-Feijóo, Marcio Andrade-Campos, Joan Gibert

|Aug 26, 2023
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.

Sara Montesdeoca, Nieves García-Gisbert, Xavier Calvo

|Oct 23, 2022
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo

|Sep 12, 2022
First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

Ramón Diez-Feijóo, Concepción Fernández-Rodríguez, Marta Lafuente

|Jun 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Xavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert

Pageof 2